Kohn E - Search Results

1

Will targeting insulin growth factor help us or hurt us?: An oncologist's perspective.

Kamrava M, Gius D, Casagrande G, Kohn E. Kamrava M, et al. Among authors: kohn e. Ageing Res Rev. 2011 Jan;10(1):62-70. doi: 10.1016/j.arr.2009.10.007. Epub 2009 Nov 5. Ageing Res Rev. 2011. PMID: 19896561 Free PMC article. Review.

2

Cell adhesion in ovarian cancer.

Elmasri WM, Casagrande G, Hoskins E, Kimm D, Kohn EC. Elmasri WM, et al. Among authors: kohn ec. Cancer Treat Res. 2009;149:297-318. doi: 10.1007/978-0-387-98094-2_14. Cancer Treat Res. 2009. PMID: 19763442 Review. No abstract available.

3

Caught in the middle: the role of Bag3 in disease.

McCollum AK, Casagrande G, Kohn EC. McCollum AK, et al. Biochem J. 2009 Dec 14;425(1):e1-3. doi: 10.1042/BJ20091739. Biochem J. 2009. PMID: 20001957 Free PMC article.

4

The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.

Simpkins FA, Devoogdt NM, Rasool N, Tchabo NE, Alejandro EU, Kamrava MM, Kohn EC. Simpkins FA, et al. Among authors: kohn ec. Carcinogenesis. 2008 Mar;29(3):466-72. doi: 10.1093/carcin/bgm212. Epub 2007 Oct 4. Carcinogenesis. 2008. PMID: 17916899

5

BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer.

Annunziata CM, Kleinberg L, Davidson B, Berner A, Gius D, Tchabo N, Steinberg SM, Kohn EC. Annunziata CM, et al. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6585-92. doi: 10.1158/1078-0432.CCR-07-0327. Clin Cancer Res. 2007. PMID: 18006758

6

Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion.

Kassis JN, Virador VM, Guancial EA, Kimm D, Ho AS, Mishra M, Chuang EY, Cook J, Gius D, Kohn EC. Kassis JN, et al. J Pathol. 2009 Aug;218(4):495-504. doi: 10.1002/path.2557. J Pathol. 2009. PMID: 19402132 Free PMC article.

7

BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expression.

Nguyen P, Bar-Sela G, Sun L, Bisht KS, Cui H, Kohn E, Feinberg AP, Gius D. Nguyen P, et al. Among authors: kohn e. Mol Cell Biol. 2008 Nov;28(21):6720-9. doi: 10.1128/MCB.00568-08. Epub 2008 Sep 2. Mol Cell Biol. 2008. PMID: 18765639 Free PMC article.

8

Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer.

Kamrava M, Simpkins F, Alejandro E, Michener C, Meltzer E, Kohn EC. Kamrava M, et al. Among authors: kohn ec. Oncogene. 2005 Oct 27;24(47):7084-93. doi: 10.1038/sj.onc.1208857. Oncogene. 2005. PMID: 16044162

9

Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.

El-Badry OM, Minniti C, Kohn EC, Houghton PJ, Daughaday WH, Helman LJ. El-Badry OM, et al. Among authors: kohn ec. Cell Growth Differ. 1990 Jul;1(7):325-31. Cell Growth Differ. 1990. PMID: 2177632

10

Insulin-like growth factors stimulate chemotaxis in human melanoma cells.

Stracke ML, Kohn EC, Aznavoorian SA, Wilson LL, Salomon D, Krutzsch HC, Liotta LA, Schiffmann E. Stracke ML, et al. Among authors: kohn ec. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1076-83. doi: 10.1016/s0006-291x(88)81338-x. Biochem Biophys Res Commun. 1988. PMID: 3291867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page